Annexin V Antikörper
(1 reference)Kurzübersicht für Annexin V Antikörper (ABIN2477449)
Target
Alle Annexin V (ANXA5) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Immunogen
- 6xHis-tagged full-length recombinant human ANXA5 (NP_001145.1).
-
Isotyp
- IgG
-
-
anti-Annexin A5 (ANXA5) (AA 1-320) antibody
ANXA5 Reaktivität: Human WB, ELISA, IP, IF, IHC (p) Wirt: Maus Monoclonal 1F4-1A5 unconjugated
anti-Annexin A5 (ANXA5) (AA 1-320) antibodyANXA5 Reaktivität: Human WB, IHC Wirt: Maus Monoclonal C13 unconjugated
anti-Annexin A5 (ANXA5) (AA 1-321) antibodyANXA5 Reaktivität: Rind (Kuh) WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Annexin A5 (ANXA5) (AA 160-320) antibodyANXA5 Reaktivität: Human, Maus WB, ELISA, ICC, FACS Wirt: Maus Monoclonal 3B9B7 unconjugated
anti-Annexin A5 (ANXA5) (AA 1-320) antibodyANXA5 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Annexin A5 (ANXA5) (AA 160-320) antibodyANXA5 Reaktivität: Human WB, ELISA, FACS Wirt: Maus Monoclonal 3B9F3 unconjugated
anti-Annexin A5 (ANXA5) (AA 88-102), (Middle Region) antibodyANXA5 Reaktivität: Human, Maus, Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Annexin A5 (ANXA5) (AA 2-320) antibodyANXA5 Reaktivität: Human, Maus, Ratte WB, IHC, ICC, IF, FACS, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Annexin A5 (ANXA5) (AA 88-102) antibodyANXA5 Reaktivität: Human, Maus, Ratte WB, ICC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Annexin A5 (ANXA5) (AA 2-320) antibodyANXA5 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "The annexins." in: Genome biology, Vol. 5, Issue 4, pp. 219, (2004) (PubMed).
-
: "The annexins." in: Genome biology, Vol. 5, Issue 4, pp. 219, (2004) (PubMed).
-
-
